SCHEMBL4336324

SCHEMBL4336324

CSC(C(N)=O)n1nc(-c2cccc(F)c2)c2cc(C(=O)O)c(C)cc21

nearest known ligand 0.38

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PTGER1 P34995 3/20 0.38
KDM4E B2RXH2 1/20 0.35
GPR35 Q9HC97 1/20 0.35
RORC P51449 1/20 0.34
PTGFR P43088 1/20 0.34
CSNK1D P48730 2/20 0.33
CSNK1E P49674 2/20 0.33
CSNK2A2 P19784 1/20 0.33
CSNK2B P67870 1/20 0.33
DCLRE1B Q9H816 1/20 0.33
HPGDS O60760 1/20 0.33
NOTUM Q6P988 1/20 0.33
KMT2A Q03164 1/20 0.33
JAK2 O60674 1/20 0.32
DHODH Q02127 1/20 0.32
ICMT O60725 1/20 0.32
MAP4K4 O95819 1/20 0.32
TACR3 P29371 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4336462 0.82 CSNK1D (0.38) PTGER1KDM4EGPR35PTGFRCSNK1D
SCHEMBL4340947 0.82 PTGER1 (0.36) PTGER1CSNK1DCSNK1EDCLRE1BNOTUM
SCHEMBL4348125 0.81 PTGER1 (0.41) PTGER1KDM4EGPR35PTGFRCSNK1D
SCHEMBL4333982 0.81 PTGER1 (0.36) PTGER1PTGFRCSNK1DCSNK1ECSNK2A2
SCHEMBL4335000 0.80 PTGER1 (0.36) PTGER1RORCPTGFRCSNK1DCSNK1E
SCHEMBL4328987 0.79 CTSA (0.41) PTGER1
SCHEMBL4343207 0.76 PTGER1 (0.38) PTGER1KDM4EGPR35PTGFRCSNK1D
SCHEMBL4342241 0.75 CSNK1E (0.34) PTGER1KDM4EGPR35RORCPTGFR
SCHEMBL4332632 0.75 PTPN11 (0.41) PTGER1KDM4EGPR35CSNK1DCSNK1E
SCHEMBL4332233 0.75 RELA (0.37) PTGER1CSNK1ECSNK2A2CSNK2BKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7541376-B2 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-06-02 US disclosed
US-20050282880-A1 Novel 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2005-12-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050282880-A1 Novel 1H-indazole compounds MAPK1, MAPK3, MAPK13 PTGER1 3143/4885KDM4E 2531/4885GPR35 1259/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.